Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort

Abstract Background Until now, herpes zoster (HZ)-related disease burden in Germany has been estimated based on health insurance data and clinical findings. However, the validity of self-reported HZ is unclear. This study investigated the validity of self-reported herpes zoster (HZ) and its complica...

Full description

Bibliographic Details
Main Authors: Mahrrouz Caputo, Johannes Horn, André Karch, Manas K. Akmatov, Heiko Becher, Bettina Braun, Hermann Brenner, Stefanie Castell, Beate Fischer, Guido Giani, Kathrin Günther, Barbara Hoffmann, Karl-Heinz Jöckel, Thomas Keil, Birgit Klüppelholz, Lilian Krist, Michael F. Leitzmann, Wolfgang Lieb, Jakob Linseisen, Christa Meisinger, Susanne Moebus, Nadia Obi, Tobias Pischon, Sabine Schipf, Börge Schmidt, Claudia Sievers, Astrid Steinbrecher, Henry Völzke, Rafael Mikolajczyk
Format: Article
Language:English
Published: BMC 2019-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-019-3691-2
_version_ 1818997387437277184
author Mahrrouz Caputo
Johannes Horn
André Karch
Manas K. Akmatov
Heiko Becher
Bettina Braun
Hermann Brenner
Stefanie Castell
Beate Fischer
Guido Giani
Kathrin Günther
Barbara Hoffmann
Karl-Heinz Jöckel
Thomas Keil
Birgit Klüppelholz
Lilian Krist
Michael F. Leitzmann
Wolfgang Lieb
Jakob Linseisen
Christa Meisinger
Susanne Moebus
Nadia Obi
Tobias Pischon
Sabine Schipf
Börge Schmidt
Claudia Sievers
Astrid Steinbrecher
Henry Völzke
Rafael Mikolajczyk
author_facet Mahrrouz Caputo
Johannes Horn
André Karch
Manas K. Akmatov
Heiko Becher
Bettina Braun
Hermann Brenner
Stefanie Castell
Beate Fischer
Guido Giani
Kathrin Günther
Barbara Hoffmann
Karl-Heinz Jöckel
Thomas Keil
Birgit Klüppelholz
Lilian Krist
Michael F. Leitzmann
Wolfgang Lieb
Jakob Linseisen
Christa Meisinger
Susanne Moebus
Nadia Obi
Tobias Pischon
Sabine Schipf
Börge Schmidt
Claudia Sievers
Astrid Steinbrecher
Henry Völzke
Rafael Mikolajczyk
author_sort Mahrrouz Caputo
collection DOAJ
description Abstract Background Until now, herpes zoster (HZ)-related disease burden in Germany has been estimated based on health insurance data and clinical findings. However, the validity of self-reported HZ is unclear. This study investigated the validity of self-reported herpes zoster (HZ) and its complication postherpetic neuralgia (PHN) using data from the pretest studies of the German National Cohort (GNC) in comparison with estimates based on health insurance data. Methods Data of 4751 participants aged between 20 and 69 years from two pretest studies of the GNC carried out in 2011 and 2012 were used. Based on self-reports of physician-diagnosed HZ and PHN, age- and sex-specific HZ incidence rates and PHN proportions were estimated. For comparison, estimates based on statutory health insurance data from the German population were considered. Results Eleven percent (95%-CI, 10.4 to 12.3, n = 539) of the participants reported at least one HZ episode in their lifetime. Our estimated age-specific HZ incidence rates were lower than previous estimates based on statutory health insurance data. The PHN proportion in participants older than 50 years was 5.9% (1.9 to 13.9%), which was in line with estimates based on health insurance data. Conclusion As age- and sex-specific patterns were comparable with that in health insurance data, self-reported diagnosis of HZ seems to be a valid instrument for overall disease trends. Possible reasons for observed differences in incidence rates are recall bias in self-reported data or overestimation in health insurance data.
first_indexed 2024-12-20T21:44:49Z
format Article
id doaj.art-7763842f46e14d79aac66fd852748306
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-20T21:44:49Z
publishDate 2019-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-7763842f46e14d79aac66fd8527483062022-12-21T19:25:42ZengBMCBMC Infectious Diseases1471-23342019-01-011911810.1186/s12879-019-3691-2Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National CohortMahrrouz Caputo0Johannes Horn1André Karch2Manas K. Akmatov3Heiko Becher4Bettina Braun5Hermann Brenner6Stefanie Castell7Beate Fischer8Guido Giani9Kathrin Günther10Barbara Hoffmann11Karl-Heinz Jöckel12Thomas Keil13Birgit Klüppelholz14Lilian Krist15Michael F. Leitzmann16Wolfgang Lieb17Jakob Linseisen18Christa Meisinger19Susanne Moebus20Nadia Obi21Tobias Pischon22Sabine Schipf23Börge Schmidt24Claudia Sievers25Astrid Steinbrecher26Henry Völzke27Rafael Mikolajczyk28Department of Epidemiology, Helmholtz Centre for Infection ResearchInstitute for Medical Epidemiology, Biometry, and Informatics (IMEBI), Medical Faculty of the Martin Luther University Halle-WittenbergDepartment of Epidemiology, Helmholtz Centre for Infection ResearchDepartment of Epidemiology, Helmholtz Centre for Infection ResearchInstitute of Public Health, University Hospital HeidelbergInstitute for Epidemiology and Social Medicine, University of MünsterDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)Department of Epidemiology, Helmholtz Centre for Infection ResearchDepartment of Epidemiology and Preventive Medicine, University RegensburgGerman Diabetes Center (DDZ), Leibniz Research for DiabetesLeibniz Institute for Prevention Research and Epidemiology – BIPSInstitute for Occupational, Social and Environmental Medicine, Heinrich-Heine-University of DüsseldorfInstitute of Medical Informatics, Biometry and Epidemiology, University Hospital EssenInstitute for Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin BerlinGerman Diabetes Center (DDZ), Leibniz Research for DiabetesInstitute for Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin BerlinDepartment of Epidemiology and Preventive Medicine, University RegensburgInstitute of Epidemiology, Christian-Albrechts-University KielHelmholtz Zentrum Munich, German Research Center for Environmental Health, Institute of Epidemiology IIHelmholtz Zentrum Munich, German Research Center for Environmental Health, Institute of Epidemiology IICentre of Urban Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, University Hospital EssenDepartment of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-EppendorfMolecular Epidemiology Research Group, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC)Institute for Community Medicine, University Medicine Greifswald, University Medicine GreifswaldInstitute of Medical Informatics, Biometry and Epidemiology, University Hospital EssenDepartment of Epidemiology, Helmholtz Centre for Infection ResearchMolecular Epidemiology Research Group, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC)Institute for Community Medicine, University Medicine Greifswald, University Medicine GreifswaldInstitute for Medical Epidemiology, Biometry, and Informatics (IMEBI), Medical Faculty of the Martin Luther University Halle-WittenbergAbstract Background Until now, herpes zoster (HZ)-related disease burden in Germany has been estimated based on health insurance data and clinical findings. However, the validity of self-reported HZ is unclear. This study investigated the validity of self-reported herpes zoster (HZ) and its complication postherpetic neuralgia (PHN) using data from the pretest studies of the German National Cohort (GNC) in comparison with estimates based on health insurance data. Methods Data of 4751 participants aged between 20 and 69 years from two pretest studies of the GNC carried out in 2011 and 2012 were used. Based on self-reports of physician-diagnosed HZ and PHN, age- and sex-specific HZ incidence rates and PHN proportions were estimated. For comparison, estimates based on statutory health insurance data from the German population were considered. Results Eleven percent (95%-CI, 10.4 to 12.3, n = 539) of the participants reported at least one HZ episode in their lifetime. Our estimated age-specific HZ incidence rates were lower than previous estimates based on statutory health insurance data. The PHN proportion in participants older than 50 years was 5.9% (1.9 to 13.9%), which was in line with estimates based on health insurance data. Conclusion As age- and sex-specific patterns were comparable with that in health insurance data, self-reported diagnosis of HZ seems to be a valid instrument for overall disease trends. Possible reasons for observed differences in incidence rates are recall bias in self-reported data or overestimation in health insurance data.http://link.springer.com/article/10.1186/s12879-019-3691-2German National CohortIncidenceSelf-reportsValidityHerpes zosterPostherpetic neuralgia
spellingShingle Mahrrouz Caputo
Johannes Horn
André Karch
Manas K. Akmatov
Heiko Becher
Bettina Braun
Hermann Brenner
Stefanie Castell
Beate Fischer
Guido Giani
Kathrin Günther
Barbara Hoffmann
Karl-Heinz Jöckel
Thomas Keil
Birgit Klüppelholz
Lilian Krist
Michael F. Leitzmann
Wolfgang Lieb
Jakob Linseisen
Christa Meisinger
Susanne Moebus
Nadia Obi
Tobias Pischon
Sabine Schipf
Börge Schmidt
Claudia Sievers
Astrid Steinbrecher
Henry Völzke
Rafael Mikolajczyk
Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort
BMC Infectious Diseases
German National Cohort
Incidence
Self-reports
Validity
Herpes zoster
Postherpetic neuralgia
title Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort
title_full Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort
title_fullStr Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort
title_full_unstemmed Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort
title_short Herpes zoster incidence in Germany - an indirect validation study for self-reported disease data from pretest studies of the population-based German National Cohort
title_sort herpes zoster incidence in germany an indirect validation study for self reported disease data from pretest studies of the population based german national cohort
topic German National Cohort
Incidence
Self-reports
Validity
Herpes zoster
Postherpetic neuralgia
url http://link.springer.com/article/10.1186/s12879-019-3691-2
work_keys_str_mv AT mahrrouzcaputo herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT johanneshorn herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT andrekarch herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT manaskakmatov herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT heikobecher herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT bettinabraun herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT hermannbrenner herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT stefaniecastell herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT beatefischer herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT guidogiani herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT kathringunther herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT barbarahoffmann herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT karlheinzjockel herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT thomaskeil herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT birgitkluppelholz herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT liliankrist herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT michaelfleitzmann herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT wolfganglieb herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT jakoblinseisen herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT christameisinger herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT susannemoebus herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT nadiaobi herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT tobiaspischon herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT sabineschipf herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT borgeschmidt herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT claudiasievers herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT astridsteinbrecher herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT henryvolzke herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort
AT rafaelmikolajczyk herpeszosterincidenceingermanyanindirectvalidationstudyforselfreporteddiseasedatafrompreteststudiesofthepopulationbasedgermannationalcohort